[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# AKRO

Novo Nordisk has completed its $4.7B acquisition of Akero Therapeutics at $XX per share plus a $X CVR tied to drug approval. Akero has been delisted from Nasdaq following the merger.

### About AKRO
AKRO is a biotechnology company focused on developing treatments for metabolic dysfunction-associated steatohepatitis (MASH).  

### Insights
- akro sentiment is up XXXXX% from the previous week.
- akro posts created is up XX% from the previous week.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:akro/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/akro/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXXX  
X Week: XXXXXXXXX +23,462%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXXX -XX%  
X Year: XXXXXXXXXX -XXXX%  
1-Year High: XXXXXXX on 2025-01-12  
1-Year Low: X on 2025-10-31  

Engagements by network (24h):
Reddit: XXX
TikTok: XXXXX
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:akro/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/akro/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX +235%  
X Months: XXXXX -XX%  
X Year: XXXXXX -XX%  
1-Year High: XXXXX on 2024-12-24  
1-Year Low: X on 2025-10-31  

Mentions by network (24h):
Reddit: XX
TikTok: XXX
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:akro/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/akro/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning AKRO in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXX +65%  
X Months: XXXXX -XX%  
X Year: XXXXX +22%  
1-Year High: XXX on 2024-12-18  
1-Year Low: X on 2025-10-31  

The most influential creators that mention AKRO in the last XX hours

| Creator                                       | Rank | Followers | Posts | Engagements |
| -------                                       | ---- | --------- | ----- | ----------- |
| [@kakist0cracy](/creator/reddit/kakist0cracy) | X    |           | X     | XX          |

[View More](/list/creators/akro/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:akro/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/akro/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% +33%  
X Month: XXX% no change  
X Months: XXX% +26%  
X Year: XXX% +32%  
1-Year High: XXX% on 2025-10-27  
1-Year Low: XX% on 2025-03-30  

Most Supportive Themes:
- MASH Treatment Focus: (55%) Akero Therapeutics is developing treatments for metabolic dysfunction-associated steatohepatitis (MASH).
- High Social Media Engagement: (35%) AKRO is experiencing frequent mentions across various social media platforms, with particularly high engagement observed on TikTok and X.
  
Most Critical Themes:
- IMPACT Trial Concerns: (1%) There are discussions and concerns regarding the mixed results from the IMPACT trial of pemvidutide in MASH.
  

### Top AKRO Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$AKRO bought by $NVO trading at XXXXX yesterday $XX cash + X non-trading CVR so u paid .65 for the cvr cvr terms: additional $X per share if Akero's drug efruxifermin receives full US approval . . . by June XX 2031. $NVO not paying $5b for failure wish i full ported"  
[X Link](https://x.com/CallsPuts1/status/1998404594603294868) [@CallsPuts1](/creator/x/CallsPuts1) 2025-12-09T14:49Z 2452 followers, XXX engagements


"Today's top X most active stocks with their YTD returns: $AKRO -XXXX% (YTD +93.6%) $BAC -XXXX% (YTD +23.3%) $HBI XXXX% (YTD -19.4%) $NVDA XXXX% (YTD +28.0%) $SPR XXXX% (YTD +9.5%)"  
[X Link](https://x.com/get_blow/status/1998404055694000495) [@get_blow](/creator/x/get_blow) 2025-12-09T14:47Z XXX followers, XX engagements


"$AKRO Merger Completed: On December X 2025 Akero Therapeutics Inc. completed a merger with Novo Nordisk A/S resulting in Akero becoming a wholly owned subsidiary. Shareholders will receive $XX in cash plus a contingent value right worth an additional $X based on future milestones"  
[X Link](https://x.com/USCorpFilings/status/1998399773490253939) [@USCorpFilings](/creator/x/USCorpFilings) 2025-12-09T14:30Z 6818 followers, XXX engagements


"$NVO $AKRO 🦉 Novo Nordisk closed its $4.7B purchase of Akero at $XX per share. The deal adds a $X CVR tied to U.S. approval of EFX and removes Akero from Nasdaq"  
[X Link](https://x.com/AponiaAnalytics/status/1998392794269045044) [@AponiaAnalytics](/creator/x/AponiaAnalytics) 2025-12-09T14:02Z 5125 followers, XXX engagements